# Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis)

> **NCT06584045** · NA · RECRUITING · sponsor: **Tongji Hospital** · enrollment: 250 (estimated)

## Conditions studied

- Encephalitis
- Encephalitis, Viral
- Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody
- Autoimmune Encephalitis

## Interventions

- **DRUG:** Calculus bovis sativus (CBS)

## Key facts

- **NCT ID:** NCT06584045
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-30
- **Primary completion:** 2029-07
- **Final completion:** 2029-12
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2025-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06584045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06584045, "Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06584045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*